These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 29510161)

  • 1. Preclinical assessment of the neutralizing efficacy of snake antivenoms in Latin America and the Caribbean: A review.
    Gutiérrez JM
    Toxicon; 2018 May; 146():138-150. PubMed ID: 29510161
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antivenomics and in vivo preclinical efficacy of six Latin American antivenoms towards south-western Colombian Bothrops asper lineage venoms.
    Mora-Obando D; Pla D; Lomonte B; Guerrero-Vargas JA; Ayerbe S; Calvete JJ
    PLoS Negl Trop Dis; 2021 Feb; 15(2):e0009073. PubMed ID: 33524033
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunological profile of antivenoms: preclinical analysis of the efficacy of a polyspecific antivenom through antivenomics and neutralization assays.
    Gutiérrez JM; Lomonte B; Sanz L; Calvete JJ; Pla D
    J Proteomics; 2014 Jun; 105():340-50. PubMed ID: 24583507
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessing the preclinical efficacy of antivenoms: from the lethality neutralization assay to antivenomics.
    Gutiérrez JM; Solano G; Pla D; Herrera M; Segura Á; Villalta M; Vargas M; Sanz L; Lomonte B; Calvete JJ; León G
    Toxicon; 2013 Jul; 69():168-79. PubMed ID: 23201503
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neutralization of four Peruvian Bothrops sp. snake venoms by polyvalent antivenoms produced in Perú and Costa Rica: preclinical assessment.
    Rojas E; Quesada L; Arce V; Lomonte B; Rojas G; Gutiérrez JM
    Acta Trop; 2005 Jan; 93(1):85-95. PubMed ID: 15589801
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preclinical assessment of the ability of polyvalent (Crotalinae) and anticoral (Elapidae) antivenoms produced in Costa Rica to neutralize the venoms of North American snakes.
    Arce V; Rojas E; Ownby CL; Rojas G; Gutiérrez JM
    Toxicon; 2003 Jun; 41(7):851-60. PubMed ID: 12782085
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preclinical Evaluation of the Efficacy of Antivenoms for Snakebite Envenoming: State-of-the-Art and Challenges Ahead.
    Gutiérrez JM; Solano G; Pla D; Herrera M; Segura Á; Vargas M; Villalta M; Sánchez A; Sanz L; Lomonte B; León G; Calvete JJ
    Toxins (Basel); 2017 May; 9(5):. PubMed ID: 28505100
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Contributions of the snake venoms of Bothrops asper, Crotalus simus and Lachesis stenophrys to the paraspecificity of the Central American polyspecific antivenom (PoliVal-ICP).
    Solano G; Gómez A; Corrales G; Chacón D; Estrada R; León G
    Toxicon; 2018 Mar; 144():1-6. PubMed ID: 29407870
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Toxicity of Bothrops sp snake venoms from Ecuador and preclinical assessment of the neutralizing efficacy of a polyspecific antivenom from Costa Rica.
    Laines J; Segura Á; Villalta M; Herrera M; Vargas M; Alvarez G; Gutiérrez JM; León G
    Toxicon; 2014 Sep; 88():34-7. PubMed ID: 24950051
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cross-reactivity of some Micrurus venoms against experimental and therapeutic anti-Micrurus antivenoms.
    de Roodt AR; Lanari LC; Ramírez JE; Gómez C; Barragán J; Litwin S; Henriët van Grootheest J; Desio M; Dokmetjian JC; Dolab JA; Damin CF; Alagón A
    Toxicon; 2021 Sep; 200():153-164. PubMed ID: 34303716
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of phylogeny, venom composition and neutralization by antivenom in diverse species of bothrops complex.
    Sousa LF; Nicolau CA; Peixoto PS; Bernardoni JL; Oliveira SS; Portes-Junior JA; Mourão RH; Lima-dos-Santos I; Sano-Martins IS; Chalkidis HM; Valente RH; Moura-da-Silva AM
    PLoS Negl Trop Dis; 2013; 7(9):e2442. PubMed ID: 24069493
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preclinical assessment of the neutralizing capacity of antivenoms produced in six Latin American countries against medically-relevant Bothrops snake venoms.
    Segura A; Castillo MC; Núñez V; Yarlequé A; Gonçalves LR; Villalta M; Bonilla C; Herrera M; Vargas M; Fernández M; Yano MY; Araújo HP; Boller MA; León P; Tintaya B; Sano-Martins IS; Gómez A; Fernández GP; Geoghegan P; Higashi HG; León G; Gutiérrez JM
    Toxicon; 2010 Nov; 56(6):980-9. PubMed ID: 20621114
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preclinical efficacy against toxic activities of medically relevant Bothrops sp. (Serpentes: Viperidae) snake venoms by a polyspecific antivenom produced in Mexico.
    Segura Á; Herrera M; Vargas M; Villalta M; Uscanga-Reynell A; León G; Gutiérrez JM
    Rev Biol Trop; 2017 Mar; 65(1):345-50. PubMed ID: 29466649
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cross-reactivity, antivenomics, and neutralization of toxic activities of Lachesis venoms by polyspecific and monospecific antivenoms.
    Madrigal M; Pla D; Sanz L; Barboza E; Arroyo-Portilla C; Corrêa-Netto C; Gutiérrez JM; Alape-Girón A; Flores-Díaz M; Calvete JJ
    PLoS Negl Trop Dis; 2017 Aug; 11(8):e0005793. PubMed ID: 28787445
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comment on "Preclinical assessment of the neutralizing capacity of antivenoms produced in six Latin American countries against medically-relevant Bothrops snake venoms".
    da Silva WD; Tambourgi DV
    Toxicon; 2011 Jun; 57(7-8):1109-10. PubMed ID: 21524658
    [No Abstract]   [Full Text] [Related]  

  • 16. Preclinical assessment of a polyspecific antivenom against the venoms of Cerrophidion sasai, Porthidium nasutum and Porthidium ophryomegas: Insights from combined antivenomics and neutralization assays.
    Gutiérrez JM; Tsai WC; Pla D; Solano G; Lomonte B; Sanz L; Angulo Y; Calvete JJ
    Toxicon; 2013 Mar; 64():60-9. PubMed ID: 23313380
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neutralization of toxicological activities of medically-relevant Bothrops snake venoms and relevant toxins by two polyvalent bothropic antivenoms produced in Peru and Brazil.
    Estevao-Costa MI; Gontijo SS; Correia BL; Yarleque A; Vivas-Ruiz D; Rodrigues E; Chávez-Olortegui C; Oliveira LS; Sanchez EF
    Toxicon; 2016 Nov; 122():67-77. PubMed ID: 27641748
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cross neutralization of coral snake venoms by commercial Australian snake antivenoms.
    Ramos HR; Vassão RC; de Roodt AR; Santos E Silva EC; Mirtschin P; Ho PL; Spencer PJ
    Clin Toxicol (Phila); 2017 Jan; 55(1):33-39. PubMed ID: 27595162
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diversity of Micrurus snake species related to their venom toxic effects and the prospective of antivenom neutralization.
    Tanaka GD; Furtado Mde F; Portaro FC; Sant'Anna OA; Tambourgi DV
    PLoS Negl Trop Dis; 2010 Mar; 4(3):e622. PubMed ID: 20231886
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reducing the impact of snakebite envenoming in Latin America and the Caribbean: achievements and challenges ahead.
    Gutiérrez JM
    Trans R Soc Trop Med Hyg; 2014 Sep; 108(9):530-7. PubMed ID: 25096295
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.